HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
In This Section
David T. Teachey, MD
Co-Leader, Immune Dysregulation Frontier Program
Dr. Teachey's research focuses on investigating novel therapeutics for children with white blood cell diseases, including ALL and a rare autoimmune disease called Autoimmune Lymphoproliferative Syndrome (ALPS). His research in ALL focuses on studying leukemic cells from children with high-risk disease.
Education and Training
BS, Virginia Commonwealth University (Biology), 1993
MD, Eastern Virginia Medical School, 1999
Fellowship, Children's Hospital of Philadelphia (Hematology/Oncology), 2005
Titles and Academic Titles
Co-Leader, Immune Dysregulation Frontier Program
Attending Physician
Associate Professor of Pediatrics
Professional Memberships
American Society of Pediatric Hematology/Oncology, 2003-
American Society of Hematology, 2003-
Children's Oncology Group, 2005-
American Society of Clinical Investigation, 2018-
Professional Awards
Charles E. Culpepper Biomedical Pilot Initiative Award, 2004
Clinical Science Research Award, Children's Hospital of Philadelphia, 2005
Judy S. Finkelstein Memorial Award in Immunology Research, 2005
American Society of Clinical Oncology Young Investigator Award, 2005
American Society of Pediatric Hematology Oncology Young Investigator Award, 2005
United States Immunodeficiency Network Research Award, 2006
American Society of Clinical Oncology Career Development Award, 2006
Larry and Helen Hoag Award in Pediatric Translational Oncology Research, 2007
Lady Barbara Colyton Prize for Autoimmune Research, University of Pennsylvania Award of Excellence, 2010
Golden and Christie Advancement Award for Saving Lives Through Rediscovery Research, 2013
American Cancer Society Research Scholar, 2014
SIOP Basic and Translational Science Research Award, 2018
Publication Highlights
PubMed: